Page last updated: 2024-09-04

docetaxel anhydrous and Breast Cancer Lymphedema

docetaxel anhydrous has been researched along with Breast Cancer Lymphedema in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Aoishi, Y; Hirai, Y; Kawaji, M; Miyasaka, M; Nishiguchi, H; Nishimura, Y; Oura, S; Shima, A	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Breast Cancer Lymphedema

Article	Year
Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration. Breast cancer (Tokyo, Japan), 2020, Volume: 27, Issue:5 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Axilla; Body Mass Index; Breast Cancer Lymphedema; Breast Neoplasms; Breast Neoplasms, Male; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Docetaxel; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Male; Mastectomy; Middle Aged; Neoadjuvant Therapy; Retrospective Studies; Risk Factors; Sentinel Lymph Node Biopsy; Upper Extremity; Young Adult	2020

Article

Year

Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.

Breast cancer (Tokyo, Japan), 2020, Volume: 27, Issue:5

Topics: Adult; Age Factors; Aged; Aged, 80 and over; Axilla; Body Mass Index; Breast Cancer Lymphedema; Breast Neoplasms; Breast Neoplasms, Male; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Docetaxel; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Male; Mastectomy; Middle Aged; Neoadjuvant Therapy; Retrospective Studies; Risk Factors; Sentinel Lymph Node Biopsy; Upper Extremity; Young Adult

2020